Transferrin-decorated CHEMS-liposomes: A nanoengineered platform for pH-responsive co-delivery of EGCG and miR-30a-5p
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Progress in natural compounds/siRNA co-delivery employing nanovehicles for cancer therapy10.1021/acscombsci.0c00099 ↗
2. Recent advances with liposomes as pharmaceutical carries10.1038/nrd1632 ↗
3. Transferrin receptors10.1038/s12276-025-01436-x ↗
4. pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells10.1016/0076-6879(93)21030-C ↗
5. Current status of pH-sensitive liposomes in drug delivery10.1016/S0163-7827(00)00011-4 ↗
6. Mimic, target, and adapt: cell membrane-coated nanoplatforms for precision and immune-guided cancer treatment
7. Thin film hydration followed by extrusion method for liposome preparation10.1007/978-1-4939-6591-5_2 ↗
8. Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells10.1038/s41598-021-90349-6 ↗
9. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
10. In vitro release kinetics model fitting of liposomes: an insight10.1016/j.chemphyslip.2016.10.005 ↗
11. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles10.1016/j.jconrel.2013.09.013 ↗
12. Optimization of docetaxel loading conditions in liposomes: proposing potential products for metastatic breast carcinoma chemotherapy10.1038/s41598-020-62501-1 ↗
13. Using UV-vis titration to elucidate novel epigallocatechin gallate (EGCG)-induced binding of the c-MYC G-quadruplex10.3390/ph18050719 ↗
14. Study of the binding of iron and indium to human serum apo-transferrin
15. Raman spectroscopy of lipids: a review10.1002/jrs.4607 ↗
16. Evaluation of aromatic amino acids as potential biomarkers in breast cancer by Raman spectroscopy analysis10.1038/s41598-021-81296-3 ↗
17. Encapsulation of epigallocatechin-3-gallate into albumin nanoparticle improves pharmacokinetic and bioavailability in rat model, 3
18. Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes10.1038/s41598-021-91866-0 ↗
19. Phase transitions and structural changes in DPPC liposomes induced by a 1-Carba-alpha-tocopherol analogue10.3390/molecules26102851 ↗
20. Multifunctional liposomes co-encapsulating epigallocatechin-3-gallate (EGCG) and miRNA for atherosclerosis lesion elimination10.1039/D3NA00369H ↗
21. Interaction of DPPC liposomes with cholesterol and food protein during in vitro digestion using dynamic light scattering and FTIR spectroscopy analysis10.1016/j.foodchem.2021.131893 ↗
22. Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and in vitro cellular studies
23. Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment10.1080/21691401.2023.2268137 ↗
24. Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior10.1016/S0005-2736(99)00186-8 ↗
25. Evaluation of EGCG loading capacity in DMPC membranes10.1021/acs.langmuir.9b00372 ↗
26. Study of the pH-sensitive mechanism of tumor-targeting liposomes10.1016/j.colsurfb.2016.11.042 ↗
27. Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model
28. Unexpected role of pH and microenvironment on the antioxidant and synergistic activity of resveratrol in model micellar and liposomal systems10.1021/acs.joc.1c01801 ↗
29. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting10.1016/j.colsurfb.2015.03.046 ↗
30. Epigallocatechin-3-gallate suppressed breast oncogenesis via miR-27a/Wnt/β-catenin pathway axis10.3389/fonc.2026.1835026 ↗